Discovery and Optimization of Highly Selective Inhibitors of CDK5

Daniels, Matthew H.; Malojcic, Goran; Clugston, Susan L.; Williams, Brett; Gal, Marie Coeffet-Le; Pan-Zhou, Xin-Ru; Venkatachalan, Srinivasan; Harmange, Jean-Christophe; Ledeboer, Mark

doi:10.1021/acs.jmedchem.1c02069

Title: Discovery and Optimization of Highly Selective Inhibitors of CDK5

Journal Article · 01 February 2022 · J. Med. Chem.

DOI:https://doi.org/10.1021/acs.jmedchem.1c02069· OSTI ID:1863041

Daniels, Matthew H.; Malojcic, Goran; Clugston, Susan L.; Williams, Brett; Gal, Marie Coeffet-Le; Pan-Zhou, Xin-Ru; Venkatachalan, Srinivasan; Harmange, Jean-Christophe; Ledeboer, Mark

Cite

Export

Save

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY

OSTI ID:: 1863041

Journal Information:: J. Med. Chem., Vol. 65, Issue (4)

Country of Publication:: United States

Language:: ENGLISH

References (54)

Autosomal dominant polycystic kidney disease Torres, Vicente E.; Harris, Peter C.; Pirson, Yves The Lancet, Vol. 369, Issue 9569 https://doi.org/10.1016/S0140-6736(07)60601-1	journal	April 2007
7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1 H -1-benzazepine (OPC-41061): A potent, orally active nonpeptide arginine vasopressin V 2 receptor antagonist Kondo, Kazumi; Ogawa, Hidenori; Yamashita, Hiroshi Bioorganic & Medicinal Chemistry, Vol. 7, Issue 8 https://doi.org/10.1016/S0968-0896(99)00101-7	journal	August 1999
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease Torres, Vicente E.; Chapman, Arlene B.; Devuyst, Olivier New England Journal of Medicine, Vol. 367, Issue 25 https://doi.org/10.1056/NEJMoa1205511	journal	December 2012
Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease Ma, Ming; Tian, Xin; Igarashi, Peter Nature Genetics, Vol. 45, Issue 9 https://doi.org/10.1038/ng.2715	journal	July 2013
Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis Husson, Hervé; Moreno, Sarah; Smith, Laurie A. Human Molecular Genetics, Vol. 25, Issue 11 https://doi.org/10.1093/hmg/ddw093	journal	April 2016
Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin-Dependent Kinases cdc2, cdk2 and cdk5 Meijer, Laurent; Borgne, Annie; Mulner, Odile European Journal of Biochemistry, Vol. 243, Issue 1-2 https://doi.org/10.1111/j.1432-1033.1997.t01-2-00527.x	journal	January 1997
Roscovitine Targets, Protein Kinases and Pyridoxal Kinase Bach, Stéphane; Knockaert, Marie; Reinhardt, Jens Journal of Biological Chemistry, Vol. 280, Issue 35 https://doi.org/10.1074/jbc.M500806200	journal	September 2005
CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD Bukanov, Nikolay O.; Moreno, Sarah E.; Natoli, Thomas A. Cell Cycle, Vol. 11, Issue 21 https://doi.org/10.4161/cc.22375	journal	November 2012
The human phosphatase CDC 14A modulates primary cilium length by regulating centrosomal actin nucleation Uddin, Borhan; Partscht, Patrick; Chen, Nan‐Peng EMBO reports, Vol. 20, Issue 1 https://doi.org/10.15252/embr.201846544	journal	November 2018
Nde1-mediated inhibition of ciliogenesis affects cell cycle re-entry Kim, Sehyun; Zaghloul, Norann A.; Bubenshchikova, Ekaterina Nature Cell Biology, Vol. 13, Issue 4 https://doi.org/10.1038/ncb2183	journal	March 2011
Casein kinase 1ε and 1α as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8 Billot, Katy; Coquil, Charlène; Villiers, Benoit American Journal of Physiology-Renal Physiology, Vol. 315, Issue 1 https://doi.org/10.1152/ajprenal.00489.2017	journal	July 2018
Cyclin dependent kinase 5: A novel avenue for Alzheimer’s disease Bhounsule, Anisha S.; Bhatt, Lokesh Kumar; Prabhavalkar, Kedar S. Brain Research Bulletin, Vol. 132 https://doi.org/10.1016/j.brainresbull.2017.05.006	journal	June 2017
CDK5: A Unique CDK and Its Multiple Roles in the Nervous System Cortés, Nicole; Guzmán-Martínez, Leonardo; Andrade, Víctor Journal of Alzheimer's Disease, Vol. 68, Issue 3 https://doi.org/10.3233/JAD-180792	journal	April 2019
Physiological and Pathological Roles of Cdk5: Potential Directions for Therapeutic Targeting in Neurodegenerative Disease Allnutt, Annamarie B.; Waters, Ariana K.; Kesari, Santosh ACS Chemical Neuroscience, Vol. 11, Issue 9 https://doi.org/10.1021/acschemneuro.0c00096	journal	April 2020
Ischemic Stroke Injury Is Mediated by Aberrant Cdk5 Meyer, D. A.; Torres-Altoro, M. I.; Tan, Z. Journal of Neuroscience, Vol. 34, Issue 24 https://doi.org/10.1523/JNEUROSCI.4368-13.2014	journal	June 2014
Targeting CDK5 post-stroke provides long-term neuroprotection and rescues synaptic plasticity Gutiérrez-Vargas, Johanna A.; Moreno, Herman; Cardona-Gómez, Gloria P. Journal of Cerebral Blood Flow & Metabolism, Vol. 37, Issue 6 https://doi.org/10.1177/0271678X16662476	journal	August 2016
Molecular roles of Cdk5 in pain signaling Utreras, Elias; Futatsugi, Akira; Pareek, Tej Kumar Drug Discovery Today: Therapeutic Strategies, Vol. 6, Issue 3 https://doi.org/10.1016/j.ddstr.2009.04.004	journal	September 2009
Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2 Brittain, Joel M.; Wang, Yuying; Eruvwetere, Omotore FEBS Letters, Vol. 586, Issue 21 https://doi.org/10.1016/j.febslet.2012.09.022	journal	September 2012
Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain Moutal, Aubin; Luo, Shizhen; Largent-Milnes, Tally M. Neurobiology of Pain, Vol. 5 https://doi.org/10.1016/j.ynpai.2018.07.003	journal	January 2019
Induction of CRMP‐2 phosphorylation by CDK5 restricts the repair of damaged optic nerve Chen, Xiaofan; Yuan, Rongdi; Gao, Ling Journal of Cellular Physiology, Vol. 234, Issue 7 https://doi.org/10.1002/jcp.27778	journal	December 2018
CDK5 in oncology: recent advances and future prospects Lenjisa, Jimma Likisa; Tadesse, Solomon; Khair, Nishat Zareen Future Medicinal Chemistry, Vol. 9, Issue 16 https://doi.org/10.4155/fmc-2017-0097	journal	October 2017
Targeting the cyclin-dependent kinase 5 in metastatic melanoma Sharma, Samanta; Zhang, Tian; Michowski, Wojciech Proceedings of the National Academy of Sciences, Vol. 117, Issue 14 https://doi.org/10.1073/pnas.1912617117	journal	March 2020
Knockdown of CDK5 down-regulates PD-L1 via the ubiquitination-proteasome pathway and improves antitumor immunity in lung adenocarcinoma Gao, Lin; Xia, Liliang; Ji, Wenxiang Translational Oncology, Vol. 14, Issue 9 https://doi.org/10.1016/j.tranon.2021.101148	journal	September 2021
Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases Schonbrunn, Ernst; Betzi, Stephane; Alam, Riazul Journal of Medicinal Chemistry, Vol. 56, Issue 10 https://doi.org/10.1021/jm301234k	journal	May 2013
Discovery of CDK5 Inhibitors through Structure-Guided Approach Khair, Nishat Z.; Lenjisa, Jimma L.; Tadesse, Solomon ACS Medicinal Chemistry Letters, Vol. 10, Issue 5 https://doi.org/10.1021/acsmedchemlett.9b00029	journal	March 2019
Potent inhibitors of CDK5 derived from roscovitine: Synthesis, biological evaluation and molecular modelling Demange, Luc; Abdellah, Fatma Nait; Lozach, Olivier Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 1 https://doi.org/10.1016/j.bmcl.2012.10.141	journal	January 2013
Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: Synthesis, neuronal cell culture investigations, and CDK5 docking studies Nair, Nanditha; Kudo, Wataru; Smith, Mark A. Bioorganic & Medicinal Chemistry Letters, Vol. 21, Issue 13 https://doi.org/10.1016/j.bmcl.2011.05.019	journal	July 2011
Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors Malmström, Jonas; Viklund, Jenny; Slivo, Can Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 18 https://doi.org/10.1016/j.bmcl.2012.07.068	journal	September 2012
A 24-Residue Peptide (p5), Derived from p35, the Cdk5 Neuronal Activator, Specifically Inhibits Cdk5-p25 Hyperactivity and Tau Hyperphosphorylation Zheng, Ya-Li; Amin, Niranjana D.; Hu, Ya-Fang Journal of Biological Chemistry, Vol. 285, Issue 44 https://doi.org/10.1074/jbc.M110.134643	journal	October 2010
TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice Shukla, Varsha; Seo, Jinsoo; Binukumar, B. K. Journal of Alzheimer's Disease, Vol. 56, Issue 1 https://doi.org/10.3233/JAD-160916	journal	January 2017
TFP5 peptide, derived from CDK5-activating cofactor p35, provides neuroprotection in early-stage of adult ischemic stroke Ji, Ya-Bin; Zhuang, Pei-Pei; Ji, Zhong Scientific Reports, Vol. 7, Issue 1 https://doi.org/10.1038/srep40013	journal	January 2017
How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases? Jorda, Radek; Hendrychová, Denisa; Voller, Jiří Journal of Medicinal Chemistry, Vol. 61, Issue 20 https://doi.org/10.1021/acs.jmedchem.8b00049	journal	September 2018
A kinase of many talents: non-neuronal functions of CDK5 in development and disease Sharma, Samanta; Sicinski, Piotr Open Biology, Vol. 10, Issue 1 https://doi.org/10.1098/rsob.190287	journal	January 2020
Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease Zhang, Chao; Balbo, Bruno; Ma, Ming Journal of the American Society of Nephrology, Vol. 32, Issue 1 https://doi.org/10.1681/ASN.2020040511	journal	October 2020
CDK5 inhibition in�vitro and in vivo induces cell death in�myeloma and overcomes the obstacle of bortezomib resistance Tang, Hailong; Xu, Li; Cen, Xi International Journal of Molecular Medicine https://doi.org/10.3892/ijmm.2020.4553	journal	March 2020
Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology Blagg, Julian; Workman, Paul Cancer Cell, Vol. 32, Issue 1 https://doi.org/10.1016/j.ccell.2017.06.005	journal	July 2017
Cyclin-dependent kinases Malumbres, Marcos Genome Biology, Vol. 15, Issue 6 https://doi.org/10.1186/gb4184	journal	January 2014
Cdk1 is sufficient to drive the mammalian cell cycle Santamaría, David; Barrière, Cédric; Cerqueira, Antonio Nature, Vol. 448, Issue 7155 https://doi.org/10.1038/nature06046	journal	August 2007
The history and future of targeting cyclin-dependent kinases in cancer therapy Asghar, Uzma; Witkiewicz, Agnieszka K.; Turner, Nicholas C. Nature Reviews Drug Discovery, Vol. 14, Issue 2 https://doi.org/10.1038/nrd4504	journal	January 2015
Features of Selective Kinase Inhibitors Knight, Zachary A.; Shokat, Kevan M. Chemistry & Biology, Vol. 12, Issue 6 https://doi.org/10.1016/j.chembiol.2005.04.011	journal	June 2005
Rational Approaches to Improving Selectivity in Drug Design Huggins, David J.; Sherman, Woody; Tidor, Bruce Journal of Medicinal Chemistry, Vol. 55, Issue 4 https://doi.org/10.1021/jm2010332	journal	January 2012
Molecular Basis of Differential Selectivity of Cyclobutyl-Substituted Imidazole Inhibitors against CDKs: Insights for Rational Drug Design Rath, Soumya Lipsa; Senapati, Sanjib PLoS ONE, Vol. 8, Issue 9 https://doi.org/10.1371/journal.pone.0073836	journal	September 2013
Conformational Adaption May Explain the Slow Dissociation Kinetics of Roniciclib (BAY 1000394), a Type I CDK Inhibitor with Kinetic Selectivity for CDK2 and CDK9 Ayaz, Pelin; Andres, Dorothee; Kwiatkowski, Dennis A. ACS Chemical Biology, Vol. 11, Issue 6 https://doi.org/10.1021/acschembio.6b00074	journal	April 2016
Conservation, Variability and the Modeling of Active Protein Kinases Knight, James D. R.; Qian, Bin; Baker, David PLoS ONE, Vol. 2, Issue 10 https://doi.org/10.1371/journal.pone.0000982	journal	October 2007
Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition Dalton, Samuel E.; Dittus, Lars; Thomas, Daniel A. Journal of the American Chemical Society, Vol. 140, Issue 3 https://doi.org/10.1021/jacs.7b08979	journal	January 2018
Gini Coefficient: A New Way To Express Selectivity of Kinase Inhibitors against a Family of Kinases ^† Graczyk, Piotr P. Journal of Medicinal Chemistry, Vol. 50, Issue 23 https://doi.org/10.1021/jm070562u	journal	November 2007
Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery Wang, Yuan; Cornett, Allen; King, Fred J. Cell Chemical Biology, Vol. 23, Issue 7 https://doi.org/10.1016/j.chembiol.2016.05.016	journal	July 2016
Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis Copeland, Robert A. Wiley https://doi.org/10.1002/0471220639	book	March 2000
NanoBRET—A Novel BRET Platform for the Analysis of Protein–Protein Interactions Machleidt, Thomas; Woodroofe, Carolyn C.; Schwinn, Marie K. ACS Chemical Biology, Vol. 10, Issue 8 https://doi.org/10.1021/acschembio.5b00143	journal	June 2015
An Unusual Member of the Cdk Family: Cdk5 Dhariwala, Fatema A.; Rajadhyaksha, Medha S. Cellular and Molecular Neurobiology, Vol. 28, Issue 3 https://doi.org/10.1007/s10571-007-9242-1	journal	January 2008
Effects of pyrrolidine dithiocarbamate on proliferation and nuclear factor-κB activity in autosomal dominant polycystic kidney disease cells Ta, Michelle H. T.; Liuwantara, David; Rangan, Gopala K. BMC Nephrology, Vol. 16, Issue 1 https://doi.org/10.1186/s12882-015-0193-3	journal	December 2015
Discovery and development of novel therapies in advanced breast cancer: rapid development of ribociclib Germa, C.; Miller, M.; Mukhopadhyay, P. Annals of Oncology, Vol. 28, Issue 8 https://doi.org/10.1093/annonc/mdx226	journal	August 2017
Structure and Regulation of the CDK5-p25nck5a Complex Tarricone, Cataldo; Dhavan, Rani; Peng, Junmin Molecular Cell, Vol. 8, Issue 3 https://doi.org/10.1016/s1097-2765(01)00343-4	journal	September 2001
Structural and Mechanistic Insights into the PAPS-Independent Sulfotransfer Catalyzed by Bacterial Aryl Sulfotransferase and the Role of the DsbL/DsbI System in Its Folding Malojčić, Goran; Owen, Robin L.; Glockshuber, Rudi Biochemistry, Vol. 53, Issue 11 https://doi.org/10.1021/bi401725j	journal	March 2014

Similar Records

Discovery and Optimization of Highly Selective Inhibitors of CDK5

Journal Article · 2022 · J. Med. Chem. · OSTI ID:1863041

Daniels, Matthew H.; Malojcic, Goran; Clugston, Susan L.; +6 more

Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology Insight

Journal Article · 2016 · Journal of Medicinal Chemistry · OSTI ID:1863041

Touré, B. Barry; Giraldes, John; Smith, Troy; +23 more

Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I–Inhibitor Design and Validation

Journal Article · 2013 · Journal of Medicinal Chemistry · OSTI ID:1863041

Zhu, Zhaoning; Sun, Zhong-Yue; Ye, Yuanzan; +18 more

Title: Discovery and Optimization of Highly Selective Inhibitors of CDK5

Citation Formats

References (54)

Similar Records

Related Subjects